Abstract:Objective: To examine the short-term outcomes of minimally invasive reoperation for severe tricuspid regurgitation after left-sided valve surgery. Methods: From January 2015 to December 2018, a total of 89 patients with severe tricuspid regurgitation after left-sided valve surgery received reoperation in Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University were included in this study. There were 21 males and 68 females, aging of (56.4±7.9) years (range: 41 to 74 years). The interval between previous left-sided valve surgery and tricuspid reoperation was (14.1±6.1) years (range: 4 to 33 years). A combination of multiple minimally invasive techniques were adopted, including endoscopy-assist right minithoracotomy approach, peripheral cannulation strategy with the vacuum-assist single venous drainage technique, heart beating technique, and temporary percutaneous pacemaker implantation, with a concomitant enhancement in preoperative right cardiac function optimization. Results: All patients received minimally invasive isolated tricuspid valve replacement (n=81) or tricuspid valve repair (n=8). After the application of multiple minimally invasive techniques, the operative mortality rate was only 3.4% (3/89). The causes of death were progressive right heart failure with multiorgan failure (n=1) and low cardiac output associated with postoperative bleeding (n=2). Regarding to the perioperative complications, renal replacement therapy rate was 5.6% (5/89), permanent pacemaker implantation rate was 1.1% (1/89), and the incidence of stroke was 0. Mechanical ventilation time was 24(24) hours, ICU stay time was 2.5 (3.0) days (M(Q(R))). During the short-term follow-up, there were no case of severe tricuspid regurgitation, 2 cases of moderate regurgitation, 4 cases of mild-to-moderate regurgitation. Conclusions: For severe tricuspid regurgitation after left-sided valve surgery, the advanced minimally invasive techniques can significantly reduce the operative mortality and morbidity. Minimally invasive bioprosthetic tricuspid valve replacement is a reliable alternative for severe tricuspid regurgitation after left-sided valve surgery.

[Surgical Treatment of Tricuspid Valve Disease Combined with Cardiac Cachexia Syndrome].

Beating-heart surgical treatment of tricuspid valve papillary fibroelastoma: A case report.

Effect of Surgical Treatment of Tricuspid Regurgitation Late after Valve Replacement of Left Heart

SURGICAL TREATMENT OF RHEUMATIC TRICUSPID DISEASE

Results of Surgical Treatment of Rheumatic Tricuspid Valve Disease Combined with Mitral and Aortic Valvular Disease in 380 Patients

Valve Replacement for Valvular Heart Disease with Giant Left Ventricle.

Combined Procedure of Surgical Treatment and Cell Transplantation for Dilated Cardiomyopathy: Initial Results

Tricuspid Valve Replacement in the Treatment of Severe Tricuspid Valve Disease: a Report of 27 Cases

Results of surgical treatment in valve disease in 70 patients

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Surgical Treatment of Tricuspid Regurgitation after Mitral Valve Surgery: a Retrospective Study in China

Surgical treatment for the patients with giant heart valve disease

Surgical treatment experience of severe rheumatic valve disease combined with large left ventricle

Minimally Invasive Valve Replacement for Late Tricuspid Regurgitation after Left-Sided Valve Surgery

Tricuspid Valve Replacement :A Clinical Analysis of 32 Cases

[Surgical Treatment of Flail Leaflet of Tricuspid Valve].

Surgical Treatment of Late Functional Tricuspid Regurgitation after Mitral Valve Replacement

Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation

Tricuspid mechanical valve replacement for severe tricuspid stenosis in a child who underwent surgical correction of complete atrioventricular septal defect, a rare long-term complications

Surgical Management of Traumatic Tricuspid Insufficiency

Minimally Invasive Isolated Tricuspid Valve Repair after Left-Sided Valve Surgery: A Single-Center Experience.